Nano X Imaging Ltd Aktie News

The visualization specialist posted its third quarter results. It beat on the bottom line and missed slightly on revenue, but investors were cheered by other developments.

Nano-X Imaging Ltd. ( NNOX ) Q3 2025 Earnings Call November 20, 2025 8:30 AM EST Company Participants Mike Cavanaugh - IR-ICR Westwicke Erez Meltzer - CEO & Acting Chairman of the Board Ran Daniel - Chief Financial Officer Conference Call Participants Ross Osborn - Cantor Fitzgerald & Co., Research Division Jeffrey Cohen - Ladenburg Thalmann & Co. Inc., Research Division Scott Henry - Alliance ...

Vaso Corporation 137 Commercial StreetPlainview, New York 11803Tel: (516) 997-4600 Fax: (516) 997-2299 Investor Contact: Jonathan NewtonInvestor RelationsPhone: 516-997-4600 Email: jnewton@vasocorporation.com PLAINVIEW, N.Y, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and healthcare IT serv...

PETACH TIKVA, Israel, Nov. 19, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company”, Nasdaq: NNOX), an innovative medical imaging technology company, today announced that the parties have agreed on the terms and conditions pursuant to which Nanox will acquire VasoHealthcare IT Inc . (“VHC IT”) from Vaso Corporation (“Vaso”) (OTCQX: VASO), subject to certain conditions.

Live demonstrations of Nanox.ARC X to be featured at RSNA booth ( 3914, South Hall Level 3) every 30 minutes Innovation Theater p resentation to highlight development of pulmonary nodule AI solution, as future component of Nanox.ARC X ; Dec 2 at 11:00am (Innovation Theater, Booth # 3316, South Hall A ) Poster p resentation : “Applications of Digital Tomosynthesis in the Musculoskeletal System” ...

Collaboration spans workers' compensation, nursing homes, and outpatient clinics PETACH TIKVA, Israel, Sept. 18, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced a collaboration between its U.S. subsidiary Nanox Impact Inc. and Monarch Medical Management and Billing LLC (“Monarch”), an experie...

Nano-X Imaging Ltd.'s Q2 results missed expectations, with revenue, EPS, and adjusted EPS all falling short and losses widening year-over-year. Despite regulatory progress and some revenue growth, core fundamentals remain weak, and cash burn is unsustainable without further dilution or new capital. Management's limited guidance and unchanged unit growth outlook highlight ongoing operational and...

Nano-X Imaging Ltd. (NASDAQ:NNOX ) Q2 2025 Earnings Conference Call August 12, 2025 8:30 AM ET Company Participants Erez I.